CM Life Sciences III Inc. License Agreements
2 Contracts & Agreements
- First Amendment to Exclusive License Agreement by and between EQRx, Inc. and Lynk Pharmaceutical (Hangzhou) Co., Ltd dated September 9, 2022 (Filed With SEC on November 10, 2022)
- First Amendment to Exclusive License Agreement by and between EQRx, Inc. and CStone Pharmaceuticals, dated August 15, 2022 (Filed With SEC on November 10, 2022)
